Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Operating Activities:
Net income	$ 129,655	$ 84,062
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	8,342	8,452
Equity in earnings of investees	(53)	(244)
Deferred income tax expense	10,273	3,783
Share-based compensation	10,399	10,636
Net pension benefit	(2,797)	(1,826)
Asset provisions	4,738	2,956
Amortization of discount on debt	5,838	5,483
Excess tax benefits from share-based payments	(7,242)
Other	439	302
Changes in assets and liabilities:
Accounts receivable	(336,013)	(316,942)
Due to consignors	303,347	298,649
Inventory	68	(10,147)
Prepaid expenses and other current assets	(2,021)	1,814
Other long-term assets	(3,226)	3,598
Income tax receivable and deferred income tax assets	(1,736)	(962)
Accrued income taxes and deferred income tax liabilities	6,730	29,469
Accounts payable and accrued liabilities and other liabilities	15,013	27,171
Net cash provided by operating activities	141,754	146,254
Investing Activities:
Funding of notes receivable	(76,460)	(104,170)
Collections of notes receivable	164,444	121,070
Capital expenditures	(8,546)	(6,954)
Distributions from equity investees	320	1,160
Increase in restricted cash	(30,637)	(9,868)
Net cash provided by investing activities	49,121	1,238
Financing Activities:
Dividends paid	(6,871)	(6,881)
Repayments of York Property Mortgage	(1,302)
Proceeds from exercise of employee stock options	2,566	9,347
Excess tax benefits from share-based payments	7,242
Funding of employee tax obligations upon the vesting of share-based payments	(18,451)	(6,300)
Net cash used by financing activities	(16,816)	(3,834)
Effect of exchange rate changes on cash and cash equivalents	8,459	(2,688)
Increase in cash and cash equivalents	182,518	140,970
Cash and cash equivalents at beginning of period	483,663	321,579
Cash and cash equivalents at end of period	$ 666,181	$ 462,549